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Abstract
Helicobacter pylori infection causes gastric cancer, the third leading cause of cancer death 
worldwide. More than half of the world’s population is infected, making universal eradication 
impractical. Clinical trials suggest that antibiotic treatment only reduces gastric cancer risk in 
patients with non-atrophic gastritis (NAG), and is ineffective once preneoplastic lesions of 
multifocal atrophic gastritis (MAG) and intestinal metaplasia (IM) have occurred. Therefore, 
additional strategies for risk stratification and chemoprevention of gastric cancer are needed. We 
have implicated polyamines, generated by the rate limiting enzyme ornithine decarboxylase 
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(ODC), in gastric carcinogenesis. During H. pylori infection, the enzyme spermine oxidase 
(SMOX) is induced, which generates hydrogen peroxide from the catabolism of the polyamine 
spermine. Herein, we assessed the role of SMOX in the increased gastric cancer risk in Colombia 
associated with the Andean mountain region when compared to the low risk region on the Pacific 
coast. When co-cultured with gastric epithelial cells, clinical strains of H. pylori from the high risk 
region induced more SMOX expression and oxidative DNA damage, and less apoptosis than low 
risk strains. These findings were not attributable to differences in the CagA oncoprotein. Gastric 
tissues from subjects from the high risk region exhibited greater levels of SMOX and oxidative 
DNA damage by immunohistochemistry and flow cytometry, and this occurred in NAG, MAG, 
and IM. In Mongolian gerbils, a prototype colonizing strain from the high risk region induced 
more SMOX, DNA damage, dysplasia and adenocarcinoma than a colonizing strain from the low 
risk region. Treatment of gerbils with either α-difluoromethylornithine (DFMO), an inhibitor of 
ODC, or MDL 72527, an inhibitor of SMOX, reduced gastric dysplasia and carcinoma, as well as 
apoptosis-resistant cells with DNA damage. These data indicate that aberrant activation of 
polyamine-driven oxidative stress is a marker of gastric cancer risk and a target for 
chemoprevention.
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Introduction
Gastric adenocarcinoma is currently the third leading cause of cancer-related death in the 
world, and approximately 723,000 persons die from this malignancy each year 
(globocan.iarc.fr). Chronic infection with Helicobacter pylori is the strongest known risk 
factor for gastric cancer,1,2 the leading global infection-associated cancer.3 H. pylori is a 
microaerophilic bacterium that selectively colonizes the stomach of the human host. 
Infection with H. pylori causes universal gastritis and the disease can progress through a 
histopathological cascade to atrophic gastritis, intestinal metaplasia, dysplasia, and gastric 
adenocarcinoma.4–7 Treatment with antibiotics is expensive and not completely effective, 
especially in high prevalence areas.8 Antibiotic-based eradication of H. pylori only reduces 
risk for cancer if given prior to the development of preneoplastic lesions.9–11 Moreover, 
epidemiologic data show a negative correlation between H. pylori infection and asthma, 
esophageal reflux disease, and eosinophilic esophagitis.12,13 These observations argue 
against universal antibiotic treatment.
Despite a very high prevalence of H. pylori infection, the incidence rates of gastric cancer 
differ greatly in high versus low altitude regions of Latin America.14,15 This has been well 
described in Colombia; in the state of Nariño, inhabitants of the Andes mountains have very 
high incidence rates of gastric cancer, as high as 150/100,000, compared to 6/100,000 in 
inhabitants of the Pacific coast, despite the fact that the two locations have similar high H. 
pylori prevalence of approximately 90% and are only 200 km apart.7,16,17 In the Andean 
region, there is a higher prevalence of precancerous lesions, namely multifocal atrophic 
gastritis (MAG), and intestinal metaplasia (IM), when compared to the low risk coastal 
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region7,18. Thus, Colombia is a vital natural laboratory for understanding gastric 
carcinogenesis.
Numerous studies have focused on mechanisms of failed immune responses, the injection of 
cytotoxin associated gene A (CagA) protein by a type IV secretion system, and the injurious 
effects of the vacuolating toxin A (VacA), all of which have been linked to gastric cancer 
risk,19–23 including in Colombia.18 However, the limited efficacy of H. pylori eradication 
strategies emphasizes the need for other pharmacologic approaches to gastric cancer 
chemoprevention. We have shown that H. pylori infection results in increased levels of 
polyamines, natural polycations that are synthesized by the rate-limiting enzyme ornithine 
decarboxylase (ODC).24,25 Infection also increases the level of spermine oxidase (SMOX), 
which catabolizes spermine and produces hydrogen peroxide (H2O2) and leads to DNA 
damage in gastric epithelial cells, a key event in the process of gastric carcinogenesis.26–29 
In the present study we demonstrate that H. pylori strains from the high risk region of 
Nariño, Colombia induce more SMOX and associated DNA damage in vitro and in vivo. We 
used inhibitors of ODC and SMOX and found that polyamine synthesis and oxidation drive 
H. pylori-associated gastric carcinogenesis in a gerbil model of gastric cancer.
Results
H. pylori clinical isolates from the high cancer region of Colombia induce more SMOX 
expression, H2O2 production, and DNA damage than isolates from the low risk region
We have reported that laboratory strains of H. pylori induce spermine oxidase (SMOX) that 
causes DNA damage in gastric epithelial cells.26,27,29 Herein we compared the ability of 10 
clinical isolates from the low risk coastal area and 10 isolates from the high risk mountain 
area to induce pathogenic responses in AGS gastric epithelial cells. These strains were all 
positive for the virulence gene cagA and for the vacA s1m1 gene alleles that have been 
linked to gastric cancer risk.21–23 All 10 high risk clinical isolates caused significantly 
increased SMOX mRNA expression compared to uninfected cells, but only three low risk 
clinical isolates caused a significant increase (Figure 1a). Overall, the high risk strains 
induced a greater increase in SMOX mRNA expression (11-fold) than the low risk strains 
(3.7-fold) when compared to uninfected control cells (Figure 1b). Similarly, there was a 
greater increase in SMOX protein expression in the AGS cells, measured as the percentage 
of SMOX-positive cells by flow cytometry, with the high risk versus low risk strains (Figure 
1c).
There was also a greater increase in H2O2 production in culture supernatants of cells 
stimulated with high versus low risk strains (Figure 1d). Levels of SMOX protein 
abundance, measured as fluorescence intensity, were also further increased with the high 
risk versus low risk isolates (Figure 1e, upper panel). In parallel, cells infected with high risk 
isolates exhibited more intense staining with a FITC-labeled 8-oxoguanosine binding 
peptide, than cells infected with low risk isolates (Figure 1e, lower panel), indicating higher 
levels of oxidative DNA damage. In cells transfected with SMOX siRNA, levels of SMOX 
(Figure 1f), H2O2 (Figure 1g) and DNA damage (Figure 1h) were significantly reduced in 
parallel, indicating that the increased oxidative stress and DNA damage caused by the high 
risk strains is SMOX-mediated. Taken together, these data suggest that H. pylori strains 
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from the high risk region exert a key effect by enhancing SMOX-dependent DNA damage in 
gastric epithelial cells.
High risk H. pylori clinical isolates induce less apoptosis despite increasing SMOX protein 
expression and DNA damage
To further assess the relationship between SMOX and DNA damage, we double-stained 
AGS cells for SMOX protein and 8-oxoguanosine, and observed a strong correlation (Figure 
2a). High risk strains significantly increased the percentage of cells that exhibited both DNA 
damage (8-oxoguanosinehigh) and SMOX expression (SMOXhigh) compared to low risk 
clinical isolates or uninfected control cells (Figure 2b). Notably, the 8-oxoguanosinehigh 
cells derive from the SMOXhigh population. We have reported that SMOX induction causes 
apoptosis in gastric epithelial cells.26,27 In the current studies, strains from both regions 
induced apoptosis, but the high risk isolates induced less apoptosis than low risk strains 
(Figure 2c). We have previously implicated the anti-apoptotic protein Bcl-2 in the regulation 
of apoptosis in response to H. pylori in gastric epithelial cells27. When measured by flow 
cytometry, levels of Bcl-2 were significantly increased by high risk strains compared to 
uninfected control cells or to cells infected with low risk strains (Figure 2d). These data 
indicate that exposure of cells to clinical isolates from the high risk region results in high 
levels of SMOX expression and DNA damage, yet promotion of cell survival due to 
increased levels of Bcl-2.
Effects of high risk versus low risk strains are not attributable to differences in CagA or 
CagA phosphorylation
CagA, the product of the H. pylori cagA virulence gene, is considered an oncoprotein 
because persons infected with cagA-positive strains have higher relative risk for gastric 
cancer, and CagA induces aberrant epithelial cell signaling.19,20,30,31 The number of type C 
EPIYA (glutamic acid-proline-isoleucine-tyrosine-alanine) motifs within the gene sequence 
has been linked to risk for gastric cancer.32–34 However, when we analyzed the 3′-ends of 
the cagA sequences from multiple clinical isolates we found no increase in the number of 
type C EPIYA motifs in the high risk strains (Figure 3a).35 When strains from both risk 
regions were co-cultured with AGS cells, all were found to translocate CagA that was 
subsequently phosphorylated; two of the low risk strains and one of the high risk strains 
demonstrated a high degree of CagA phosphorylation (Figure 3a). These data suggest that 
differences in induction of SMOX and DNA damage between high and low risk strains are 
not due to differences in CagA translocation and phosphorylation.
SMOX expression and oxidative DNA damage are increased in H. pylori gastritis tissues 
from high risk versus low risk Colombian subjects
Because we identified differences in the ability of H. pylori strains from high and low risk 
subjects to induce SMOX in vitro, we examined gastric biopsies from the source patients. 
Biopsies from subjects in the high risk region demonstrated SMOX immunostaining in the 
gastric epithelium of non-atrophic gastritis (NAG) that was greater than that in NAG of low 
risk subjects, and was strongly increased in metaplastic glands in the IM cases (Figure 4a, 
upper panel). There was also increased staining for 8-OHdG, a marker for oxidative DNA 
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damage, in epithelial nuclei in areas of NAG and IM in biopsies from the high risk region, 
that was less apparent in tissues from the low risk region (Figure 4a, lower panel). When 
quantified, SMOX staining was significantly increased in high risk versus low risk subjects 
(Figure 4b). Further, at each stage of NAG, MAG, and IM, the level of SMOX staining was 
higher in the high versus low risk tissues and peaked in the IM tissues (Figure 4c).
When we compared our published data for 8-OHdG staining in these subjects7 with SMOX 
staining, a strong correlation was observed (Figure 4d). We performed flow cytometry on 
isolated gastric epithelial cells from cases where frozen biopsies were available, and found a 
significant increase in SMOX (Figure 4e) and 8-oxoguanosine (Figure 4f) levels, and 
percentage of positive cells (Figure 4g) in high risk versus low risk subjects. Nearly all of 
the 8-oxoguanosinehigh cells were SMOXhigh (Figure 4g) and this double-positive 
population was increased in the high risk subjects (Figure 4h).
Increased carcinogenesis with high risk versus low risk H. pylori in gerbils
We next employed a model of H. pylori-induced gastric cancer in Mongolian gerbils that 
closely recapitulates the human disease.36–38 We infected groups of five gerbils with five 
different high risk (PZ5056, PZ5069, PZ5086, PZ5097, and PZ5114) or five low risk 
(PZ5009, PZ5010, PZ5024, PZ5033, and PZ5047) clinical isolates. Two low risk clinical 
isolates, PZ5009 (5/5 gerbils) and PZ5010 (1/5 gerbils), and one high risk strain, PZ5056 
(4/5 gerbils), were recovered from the gerbil stomachs. The colonization with H. pylori was 
confirmed by Steiner staining of tissues (Figure 5a). While the low risk strains only induced 
gastritis, the high risk PZ5056 strain induced hyperplasia and dysplasia (Figure 5a). There 
was minimal SMOX staining in stomachs infected with the low risk PZ5009 isolate (Figure 
5a, upper panel), but there was increased SMOX staining in the PZ5056-infected gerbils that 
was predominantly localized to dysplastic glands (Figure 5a, lower panel). Having identified 
these in vivo differences, we also tested strains PZ5009 and PZ5056 in an additional gastric 
epithelial cell line, namely murine conditionally-immortalized stomach cells (ImSt). The 
high risk PZ5056 strain induced higher levels of SMOX, H2O2, and DNA damage in these 
gastric epithelial cells when compared to the low risk PZ5009 strain (Supplementary Figure 
S1).
Based on prior studies demonstrating increased oncogenic potential and colonization 
efficiency with a gerbil-adapted strain,37,38 we tested gerbil-passaged low risk PZ5009 and 
high risk PZ5056 output strains, which we termed PZ5009G and PZ5056G, respectively. 
These strains were utilized as prototype high and low risk strains. Both strains colonized the 
gerbils and induced a similar level of gastritis, indicating adaptation to the gerbil host. 
However, there was an increased frequency of both dysplasia and invasive adenocarcinoma 
in gerbils colonized with the high risk PZ5056G compared to the low risk PZ5009G (Figure 
5b). There was diffuse gastritis induced by both strains, and invasive adenocarcinoma with 
strain PZ5056G (Figure 5c), including invasion of malignant glands into the submucosa 
(Figure 5c). Further, there was increased SMOX staining in dysplastic glands, particularly in 
invasive glands characteristic of carcinoma (Figure 5c). Flow cytometry performed on 
isolated gastric epithelial cells revealed a significant increase in both SMOX (Figure 5d) and 
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8-oxoguanosine levels (Figure 5e) in gerbils infected with PZ5056G versus PZ5009G. There 
was also a significant correlation of SMOX and DNA damage in these cells (Figure 5f).
To further test the oncogenic potential of the two gerbil-adapted strains, epithelial cells were 
isolated from gerbils 4 weeks post-inoculation and soft agar assays performed. Cells from 
gerbils infected with PZ5056G grew in an anchorage-independent manner on soft agar, but 
this did not occur in cells from gerbils infected with PZ5009G (Figure 5g and 5h). These 
data indicate the presence of transformed cells in response to infection with the gerbil-
adapted high risk strain early in the infection course.
Together these data indicate that there are differences in oncogenic potential of high versus 
low risk strains and implicate SMOX-dependent oxidative DNA damage in these responses.
Role of CagA in vivo in induction of gastric cancer, SMOX and DNA damage
CagA has been directly linked to gastric carcinogenesis, and we have reported that 
laboratory strains with cagA deletion induce less SMOX and DNA damage. We therefore 
constructed a cagA isogenic mutant of PZ5056G, which was verified by Western blotting 
(Supplementary Figure S2a). Compared to the wild-type strain, the cagA− strain caused less 
histologic gastritis (Figure 6a) and higher colonization levels (Figure 6b). There was 
complete loss of gastric dysplasia or cancer development with the cagA mutant (Figure 6c). 
Gerbils infected with PZ5056G cagA− exhibited markedly attenuated SMOX (Figure 6d) 
and 8-oxoguanosine (Figure 6e) levels in gastric epithelial cells compared to those infected 
with PZ5056G. Similarly, there was less SMOX staining in gastric biopsies from human 
subjects infected with cagA− strains, compared to subjects infected with cagA+ strains 
(Supplementary Figure S3). Together, these data indicate that in vivo, CagA is necessary for 
increased levels of SMOX, DNA damage, and gastric carcinogenesis.
We also assessed the effect of cagA deletion in PZ5056G and in the PZ5056 pre-adapted 
clinical strain in vitro. There was a partial inhibition of the stimulated SMOX mRNA 
expression in AGS gastric epithelial cells with the cagA− strains (Supplementary Figure 
S2a). We also assessed the effect of cagA deletion in two additional high risk clinical strains, 
and there was a similar effect (Supplementary Figure S2b).
Inhibition of polyamine synthesis or metabolism reduces gastritis and gastric 
carcinogenesis in infected gerbils
To provide further translational relevance, gerbils infected with the cancer-inducing strain 
PZ5056G were treated with the ODC inhibitor, α-difluoromethylornithine (DFMO), the 
SMOX inhibitor, MDL 72527, or the combination. We verified in a subset of gerbils that 
DFMO reduced levels of the polyamines putrescine, spermidine, and spermine in infected 
animals (Figure 7a), thus resulting in decreased substrate availability for the SMOX enzyme. 
We also found that there was a positive correlation between polyamine levels and both 
gastric inflammation scores (Figure 7b) and DNA damage (Figure 7c).
Administration of either of the inhibitors alone or in combination resulted in significant, but 
modest decreases in gastritis scores (Figure 8a). Further, in each of the groups, the highest 
levels of gastritis were associated with dysplasia or carcinoma (Figure 8a). We also 
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observed a modest, but significant inhibitory effect on levels of H. pylori colonization with 
the inhibitors (Supplementary Figure S4).
There was a marked inhibitory effect on gastric carcinogenesis with the disruption of 
polyamine synthesis by DFMO or spermine metabolism by MDL 72527. The incidence of 
dysplastic lesions was significantly reduced by 51% in gerbils treated with DFMO compared 
to non-treated gerbils (Figure 8b, left panel and Figure 8c). MDL 72527 also caused a 38% 
reduction in dysplasia (Figure 8b, left panel) and both inhibitors together produced a 60% 
reduction (Figure 8b, left panel). Similarly, gastric adenocarcinoma was significantly 
reduced by 58% with DFMO, 56% with MDL72527, and 71% with the combination 
treatment (Figure 8b, right panel).
Inhibition of polyamine synthesis or metabolism reduces gastric epithelial cells with DNA 
damage and cells with DNA damage that are resistant to apoptosis in infected gerbils
We have reported that H. pylori infection in gerbils increases gastric epithelial cells with 
DNA damage (8-oxoGhigh) and apoptosis (active caspase-3high), but also leads to a 
subpopulation of cells with DNA damage that are resistant to apoptosis (8-oxoGhigh, active 
caspase-3low) as assessed by flow cytometry.27 In the current studies, treatment with DFMO 
or MDL 72527 alone or in combination reduced the number of 8-oxoGhigh (Figure 9A) or 
active caspase-3high (Figure 9B) cells. The inhibitors also significantly reduced the 8-
oxoGhigh, active caspase-3low cells (Figure 9C). Thus, inhibition of polyamine synthesis and 
oxidation can reduce cellular events related to gastric carcinogenesis.
Discussion
H. pylori-associated gastric cancer is a multifactorial process. In addition to host and 
environmental factors, H. pylori genotypes play a significant role in carcinogenesis. 
Epidemiological data suggest a link between H. pylori virulence factors, especially CagA, 
and gastric cancer.19–22 CagA has been implicated in H. pylori-induced apoptosis, 
proliferation, oxidative stress, and DNA damage in gastric epithelial cells.19,28,39 In the 
present study, all H. pylori clinical strains used in our cell culture models were positive for 
cagA, and for the vacA s1m1 allele, so we excluded potential differences in these virulence 
genes. Despite substantial increases in the ability of the high risk versus low risk strains to 
induce SMOX, oxidative stress, and DNA damage, these affects were not attributable to 
differences in their EPIYA motifs or the translocation and phosphorylation of CagA, which 
are linked to carcinogenesis.19,21,28,35 We have reported that in response to North American 
H. pylori clinical isolates, the induction of SMOX expression in gastric epithelial cells was 
greater in strains that expressed CagA.27 In the current study, the effect of cagA deletion in 
different strains on SMOX expression in gastric epithelial cells was only partial. Thus, a 
component of the ability of Colombian high risk strains to induce SMOX may be 
independent of CagA, at least in vitro.
Importantly, in the gerbil model, a cagA mutant of the cancer-inducing PZ5056G strain 
induced little inflammation and no dysplasia or carcinoma, despite colonizing well. These 
data suggest that CagA and inflammation are both required for gastric carcinogenesis, 
consistent with other studies in the gerbil model.27,37,38 Thus, CagA may be required for 
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carcinogenesis, but alone it is not sufficient. Furthermore, our results in the gerbil model 
were obtained by initiating the studies with randomly selected high risk and low risk strains 
that were all cagA+, suggesting that our findings are representative. Moreover, of the high 
risk strains tested in gerbils, two strains (PZ5056 and PZ5097) induced levels of SMOX 
mRNA above the mean level in vitro, and the other 3 strains tested induced levels of SMOX 
mRNA below the mean level for the high risk strains in the co-culture assays, indicated the 
in vivo studies were conducted with representative strains. Colonization occurred with 20–
40% of the tested clinical isolates. We subsequently tested an additional 8 strains from each 
region in gerbils, and we were able to recover H. pylori with 25% of the high risk strains and 
50% of the low risk strains, indicating that our initial results were typical for these clinical 
isolates.
Conflicting findings between cell culture and animal models pertaining to the role of CagA 
have been well-recognized.19 An important additional consideration is that inflammatory 
factors such as macrophage-derived TNF-α promote gastric tumorigenesis.40 Further, TNF-
α induces SMOX in lung epithelial cells.41 Because the level of gastric inflammation was 
similar in gerbils infected with the high risk or low risk gerbil-adapted strains, it is apparent 
that inflammation alone is not sufficient alone for carcinogenesis. Thus, other factors are 
important and may involve differential expression of a variety of genes associated with 
virulence phenotypes that appear to be enhanced in high risk strains.42
Excessive gastric epithelial apoptosis has been considered to be highly pathogenic, since it 
can lead to barrier dysfunction, and compensatory cell proliferation.28,43,44 However, 
insufficient apoptosis in cells with DNA damage is problematic, as it can lead to failed 
clearance of cells with damaged DNA. We have previously demonstrated that in both the 
gerbil model of carcinogenesis and in hypergastrinemic mice with dysplasia, H. pylori 
infection is associated with a subpopulation of gastric epithelial cells with DNA damage that 
are resistant to apoptosis.27 In the present study, we showed that high risk strains induced 
more anti-apoptotic Bcl-2 and less apoptosis than low risk strains in vitro, and in parallel, 
the gerbil-adapted high risk strain caused generation of cells that were 8-oxoguanosinehigh, 
active caspase-3low in infected gerbils, indicative of cells that simultaneously exhibit DNA 
damage and resistance to apoptosis. We recently reported that phosphorylation of epidermal 
growth factor receptor (EGFR) and ERBB2 is associated with the resistance to apoptosis in 
infected gastric epithelial cells, and that levels of pEGFR and pERBB2 were increased at 
baseline in gastric tissues from subjects in the high risk region of Colombia that later had 
progression of gastric lesions in a longitudinal cohort of subjects distinct from the current 
cross-sectional study.29 Thus, studies of the effect of high risk versus low risk strains on 
activation of EGFR and ERBB2 are a target of our future investigations.
Recently our group has demonstrated that the greatest risk for advanced gastric histology in 
Colombia was associated with loss of co-evolution of H. pylori and their respective human 
hosts.45 In future studies, including in additional Latin American high and low risk sites, we 
plan to incorporate whole genome sequencing of H. pylori and high density human genetic 
analyses; through such methods we can prospectively determine the bacterial and human 
factors affecting pathways of carcinogenesis, such as polyamine-mediated oxidative DNA 
damage. Moreover, by using whole genome sequencing we expect to identify genetic 
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differences between high and low risk strains that can be studied further; as candidate genes 
are elucidated, this can be addressed by using deletion mutants in H. pylori strains for 
mechanistic studies using our in vitro and in vivo models.
Another key point is that clinical trial data indicate that antibiotic eradication of H. pylori is 
effective in reducing risk for gastric cancer in subjects with NAG, but not in those with more 
advanced lesions.9–11 Because MAG and IM are very prevalent in high risk populations, 
such as in Colombia,7,46 additional treatment strategies are needed. Our data in the gerbil 
model provide a rationale for targeted chemoprevention in high risk subjects based on 
interference with polyamine-mediated oxidative stress. While our studies indicate that 
SMOX is both a disease marker and a key cause of oxidative DNA damage, there are no 
SMOX inhibitors available for human use. In contrast, DFMO has been successfully utilized 
in human Phase 2 clinical trials for prevention of colonic adenomatous polyps, where 
efficacy and safety has been demonstrated.47,48 Because our data show a benefit of DFMO 
in prevention of dysplasia and carcinoma in the gerbil model, we consider ODC to be a 
promising target in populations at high risk for gastric cancer, such as in mountainous areas 
of Latin America. Our finding of a modest additive benefit with DFMO plus MDL 72527 
most likely reflects the incomplete enzyme inhibition with the respective monotherapies, but 
also suggests that other drugs in combination with DFMO such as future inhibitors of 
SMOX or inhibitors of polyamine uptake may be efficacious against gastric cancer.
Materials and Methods
Reagents
All reagents used for cell culture and RNA extraction were obtained from Invitrogen 
(Carlsbad, CA). Reagents for cDNA synthesis and real-time PCR were purchased from Bio-
Rad (Hercules, CA). N′,N2-bis(2,3-butadienyl)-l,4-butanediamine (MDL 72527) was 
synthesized by PMW as described,49 and DFMO was provided by PMW. All other 
chemicals were purchased from Sigma.
Human subjects
Data in this study was derived from male subjects (ages 39–60) in Colombia from the high 
cancer risk region (Tuquerres) in the Andes Mountains and the low cancer risk region 
(Tumaco) on the Pacific Coast and were enrolled according to Institutional Review Board 
protocols approved by Vanderbilt University and Universidad del Valle Ethics Committees, 
all as described.7 Histopathology of gastric biopsies was assessed in the diagnostic 
categories of normal, non-atrophic gastritis (NAG), multifocal atrophic gastritis (MAG), 
intestinal metaplasia (IM), and dysplasia by two pathologists (MBP and PC), as described.7
H. pylori clinical strains and isogenic mutants
H. pylori was isolated from gastric biopsies.7 In the initial studies five H. pylori cagA+, 
vacA+ s1m1 clinical isolates from each region were randomly selected for both the in vitro 
and in vivo experiments. Subsequently, an additional five low risk and five high risk H. 
pylori cagA+, vacA+ s1m1 clinical isolates were used for the in vitro studies, for a total of 10 
from each region. Isogenic cagA mutants were made by insertion mutagenesis using the 
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pMC3::Km vector.50 For in vitro experiments, clinical isolates and isogenic mutants were 
grown on blood agar plates under microaerobic conditions.27
Cell and culture conditions
AGS cells were grown in F12 medium.26 Clinical isolates were co-cultured with AGS cells 
for 4, 6 or 24 h. In addition, conditionally-immortalized stomach cells derived from the 
immortomouse were infected under non-permissive conditions as described.27 A multiplicity 
of infection (MOI) of 200 was used for in vitro studies.
Real-time polymerase chain reaction
Isolation of RNA from AGS cells, cDNA synthesis, primer sequences for human SMOX and 
β-actin, real-time PCR using SYBR green, and relative expression of SMOX were all as 
described.26,27
Detection of SMOX protein, DNA damage (8-oxoguanosine) and Bcl-2 protein by flow 
cytometry
Assessment of each of these parameters was conducted as described.26,27,29
Measurement of H2O2
2.5 × 106 cells were plated in 6-well plates and H2O2 was measured in supernatants by 
Amplex Red assay.24,26
Transient transfection of SMOX siRNA
Small interfering RNA (siRNA) duplexes that targeted human SMOX and a scrambled small 
interfering RNA with no sequence homology to any known genes were transfected, as 
described.24,26
Apoptosis
Apoptosis was assayed using annexin V; 2.5 × 106 cells were stained and acquired by flow 
cytometry using a BD LSR II, and cells analyzed as described.24,26,27
Immunohistochemistry
Paraffin-embedded tissues were deparaffinized, antigen retrieval was performed, and tissues 
were stained with polyclonal rabbit anti-SMOX antibody (provided by RAC, dilution 
1:10,000) and monoclonal mouse anti-8-hydroxy-2′-deoxyguanosine (8-OHdG; dilution 
1:4000; Abcam, Cambridge, MA), and staining intensity was scored, all as described.7,27,29
Isolation of epithelial cells from gastric tissue
Gastric epithelial cells were isolated from frozen tissues by dissociation and dispersion.27 
After washing, cells were fixed with 0.1% paraformaldehyde and used for flow cytometry.
Western blotting for total and phosphorylated CagA
Immunoblotting for CagA and pCagA was performed as described in AGS cells co-cultured 
with H. pylori strains grown overnight in brucella broth.27,51
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Gerbil infection with H. pylori clinical isolates
Ten groups of 5 male Mongolian gerbils (Harlan Labs, Indianapolis, IN) aged 6–8 weeks, 
were each inoculated37,38 with one of the 5 low risk or 5 high risk strains. Gerbils were 
euthanized 12 weeks after challenge and stomachs were divided longitudinally into linear 
strips from the squamocolumnar junction to the duodenum.37,38 Strips were fixed, 
embedded and sections were stained with hematoxylin and eosin for histology,37,38 and with 
modified Steiner silver stain for detection of H. pylori.52 Inflammation (acute and chronic) 
were each scored on a 0–3 scale based on the Sydney System,25,53 and dysplasia and 
adenocarcinoma diagnosed as described.37,38 Strips were also used to culture H. pylori, 
which was quantified as described.25 In addition qPCR was performed for ureA.25 
Recovered single colonies were isolated from gerbils and propagated. Additional gerbils 
were orogastrically challenged with gerbil-adapted strains and euthanized 16 weeks post-
inoculation.
For intervention studies, gerbils were challenged with the gerbil-adapted high risk strain. 
Gerbils were treated with DFMO (1% w/v in drinking water)25 or with 100 μl (20 mg/kg) of 
MDL 72527 in PBS administered via intraperitoneal injection three times a week,54 both 
beginning 7 days prior to infection and continued for the duration of the experiment. Gerbils 
were euthanized 16 weeks after inoculation and studies were performed on gastric tissues as 
above.
Colony formation assay
Gerbil gastric epithelial cells were isolated and positively selected using a magnetic column 
and E-cadherin antibody (BD Biosciences, San Jose, CA). Purified cells were suspended in 
0.3% agar with F12 medium supplemented with 10% fetal bovine serum, plated at a density 
of 5×104 cells in 60 mm dishes coated with 0.5% base agar, and maintained at 37°C. Fresh 
complete medium was added every five days. On day 21, the number of cells was counted at 
four locations in each dish.
Measurement of polyamine concentration
Polyamine levels were determined by high performance liquid chromatography as 
reported.25,55
Statistics
Statistical analyses were performed using Prism 5.0 (GraphPad Software, San Diego, CA). 
When comparisons between multiple groups were made, analysis of variance with the 
Student-Newman-Keuls posthoc multiple comparisons test was performed. Student’s t test 
was performed when comparisons between only 2 groups were made. Contingency analyses 
were performed using chi-square or Fisher’s exact test as appropriate. A P value of <0.05 
was considered significant. In all figures, where histogram plots were used, means ± 95% 
confidence intervals are shown; for bar graphs, means ± standard errors are shown.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Clinical isolates from the high risk region of Colombia induce higher levels of SMOX 
expression, H2O2, and DNA damage. AGS cells were co-cultured with clinical isolates from 
the low and high risk regions. (a and b) After 6 h, levels of SMOX mRNA were measured 
by real-time PCR. (c) Percentage of SMOXhigh (SMOX-positive) cells after 24 h co-culture, 
assessed by flow cytometry. (d) Levels of H2O2 in cell culture supernatants after 24 h by 
Amplex Red assay. (e) Representative histograms for SMOX and 8-oxoguanosine. (f–h) 
Cells were transfected with scrambled (Scr) siRNA or SMO siRNA and activated with 
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strains from each risk region for 24 h, and summary data is shown. (f) SMOX protein levels 
in mean fluorescence units assessed by flow cytometry. (g) Levels of H2O2 in cell culture 
supernatants. (h) DNA damage measured by flow cytometry for 8-oxoguanosine levels. In 
a-h, data is from at least three experiments in duplicate. For a-d, *P < 0.05, **P < 0.01, 
***P < 0.001 versus control (Ctrl); §§§P < .001 versus low risk. For f–h, *P < .05, ***P < 
0.001 versus Scr control; §§§P < 0.001 versus Scr low risk or Scr high risk. ###P < 0.001 
versus Scr low risk. For a, b, c, and e, 10 strains from each region were used; for d, 7 strains 
from each region were used, and for f–h, 4 strains from each region were used.
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Figure 2. 
Correlation between SMOX and DNA damage, and levels of apoptosis and Bcl-2 in AGS 
cells co-cultured with clinical isolates for 24 h. (a) Correlation (Pearson coefficient) between 
the percentage of cells positive for SMOX and 8-oxoguanosine levels determined by flow 
cytometry. (b) Percentage of SMOX+, 8-oxoguanosine+ double-positive cells by flow 
cytometry. (c) Summary data for apoptosis measured by annexin V and propidium iodide 
(PI) using flow cytometry. (d) Summary data for levels of Bcl-2 measured by flow 
cytometry. For ad, at least three experiments were performed in duplicate. In b–d, *P < 0.05, 
***P < 0.001 versus control (Ctrl); §§P < 0.01, §§§P < 0.001 versus low risk. Ten strains 
from each risk group were used.
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Figure 3. 
CagA in high and low risk strains. Upper panel: analysis of EPIYA motifs of clinical 
isolates; numbers of type C motifs are indicated. Lower panels: AGS cells were co-cultured 
with clinical strains for 4 h and Western blotting was performed for phosphorylated CagA 
and total CagA using antibodies to pY99, CagA, and β-actin.
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Figure 4. 
Levels of SMOX and DNA damage in Colombian human subjects. (a) 
Immunohistochemistry for SMOX and 8-OHdG at 200X and 600X magnification. (b) 
Scoring of SMOX staining intensity in epithelial cells from immunohistochemistry analysis. 
(c) SMOX staining determined in uninfected controls with normal histology, and subjects 
with NAG, MAG, and IM. (d) Correlation (Spearman coefficient) between SMOX and 8-
OHdG levels in immunohistochemistry. (e–h) Gastric epithelial cells were isolated from 
gastric biopsies and flow cytometry was performed for SMOX and 8-oxoguanosine. (e) 
Representative histograms for levels of SMOX and 8-oxoguanosine. (f) Representative dot 
plots for SMOX and 8-oxoguanosine with the percent of cells in each quadrant marked. (h) 
Summary data for percentage of cells that were SMOX+, 8-oxoguanosine+. In b, **P < 0.01 
versus low risk; in c, **P < 0.05, P < 0.01, P < 0.001 versus normal; §P < 0.05, §§P < 0.01 
for high risk versus low risk; (h) §§P < 0.01 versus low risk. For a-d, 29 low risk and 35 
high risk subjects were studied. For e–h, 10 low risk and 10 high risk subjects were used.
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Figure 5. 
Increased oncogenic potential of H. pylori from the high risk region in the gerbil model. (a) 
Upper and lower panels: photomicrographs from gastric tissues from animals infected with 
low risk strain PZ5009 and high risk strain PZ5056, respectively. Left panels: Steiner 
(modified silver) staining of H. pylori. Middle panels: H&E staining, with hyperplasia and 
dysplastic glands shown for strain PZ5056. Right panels: SMOX immunohistochemical 
staining, with increase in dysplastic glands of PZ5056-infected gerbil. (b) Frequency of high 
grade dysplasia or carcinoma in gerbils infected with gerbil-adapted low risk (PZ5009G) 
and high risk (PZ5056G) strains. n = 19 and 20 gerbils were infected with PZ5009G and 
PZ5056G, respectively. (c) Left panel and middle panels: H&E staining of gerbil stomach 
tissues, showing invasive malignant-appearing glands with PZ5056G, and diffuse gastritis 
with both strains. Right panels: Staining for SMOX showing more intense staining in 
dysplastic glands with PZ5056G infection. (d–f) Flow cytometry performed on gastric 
epithelial cells isolated from stomach tissues. (d) SMOX protein levels. (e) 8-oxoguanosine 
levels. (f) Correlation (Spearman coefficient) between SMOX-positive cells and 8-
oxoguanosine levels. (g) Brightfield photomicrographs of cells from soft agar assays of cells 
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isolated from gerbils infected with strains PZ5009G and PZ5056G. (h) Summary data for 
number of cells counted in 6 fields at 100X. n = 4 gerbils were infected with each strain for 
4 weeks and gastric epithelial cells were isolated and plated on three different soft agar 
coated plates per stomach. In d and e, **P < 0.01, ***P < 0.001 versus control (Ctrl); §§P < 
0.01, §§§P < 0.001 versus PZ5009G. For h, ***P < 0.001 versus PZ5009G.
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Figure 6. 
Diminished gastric pathology in gerbils infected with cagA isogenic mutant of oncogenic 
strain PZ5056G. Gerbils were infected with the PZ5056G parental strain or the cagA 
isogenic mutant for 16 weeks. (a) Gastric inflammation in tissues assessed by H&E staining 
and scoring of the levels of acute and chronic gastritis in antrum and corpus. (b) 
Colonization by serial dilution and culture. (c) Frequency of gastric dysplasia and invasive 
carcinoma. Note that with the cagA− strain there were no cases of dysplasia or carcinoma. (d 
and e) Gastric epithelial cells were isolated from stomach tissues and flow cytometry 
performed. (d) SMOX protein levels. (e) 8-oxoguanosine levels. In a, data are from 19 and 
13 gerbils infected with PZ5056G and the PZ5056G cagA isogenic mutant, respectively. In 
d and e, stomach tissues from gerbils infected with PZ5056G (n = 9) and PZ5056G cagA− (n 
= 10) were used. For a and b, §§P < 0.01 and §§P < 0.001 versus PZ5009G. For d and e, *P 
< 0.05, **P < 0.01 versus control (Ctrl); §§P < 0.01, §§§P < 0.001 versus PZ5009G.
Chaturvedi et al. Page 23
Oncogene. Author manuscript; available in PMC 2015 December 01.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 7. 
Levels of polyamines in gerbils. Gerbils were infected with PZ5056G or sham gavaged with 
broth. Animals were treated with DFMO (1% w/v given continuously in the drinking water) 
and MDL72527 (20 mg/kg given in 100 μl intraperitoneal injections, 3 times per week), 
with both beginning 7 days prior to inoculation with H. pylori and treatments continued for 
the duration of the experiment. After 16 weeks of infection, polyamines were measured from 
gastric tissues by HPLC. (a) Levels of putrescine, spermidine, spermine, and total 
polyamines. n = 10 gerbils per group, ***P < 0.001 versus control (uninfected); §P < 0.05, 
§§P < 0.01, §§§P < 0.001 versus non-treated. (b and c) Correlation (Spearman coefficient) 
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between total polyamines and gastritis score (b) or 8-oxoguanosine-positive cells (c). n = 20 
gerbils from the untreated, infected group were used.
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Figure 8. 
Effect of DFMO and MDL 72527 on PZ5056G-induced gastric pathology. Gerbils were 
infected with PZ5056G and treated with DFMO (D) or MDL 72527 (M) or the combination 
(D+M) as described in Figure 7. After 16 weeks gerbils were euthanized. (a) Gastritis score 
was assessed as in Figure 6. Each symbol represents a gerbil, with orange symbols 
indicating animals with dysplasia, and red symbols animals with carcinoma. All gerbils with 
no histologic gastritis were colonized when assessed by either culture or qPCR for the ureA 
gene. *P < 0.05 versus PZ5056G without treatment. (b) Frequency of advanced lesions. Left 
panel: dysplasia; right panel: carcinoma. (c) Representative H&E staining showing 
malignant appearing glands invading into the submucosa, top panels; and only gastritis in a 
gerbil treated with DFMO.
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Figure 9. 
Percentage of epithelial cells with DNA damage, apoptosis, and DNA damage with 
apoptosis resistance in gerbil gastric tissues. Gerbils were infected with PZ5056G for 16 
weeks and were treated with DFMO, MDL 72527 or the combination. Gastric epithelial 
cells were isolated from gerbil stomachs and stained for 8-oxoguanosine and active 
caspase-3, and flow cytometry was performed. (a) Percent DNA damage-positive cells, by 
gating on cells with high levels of 8-oxoguanosine. (b) Percent apoptosis-positive cells, by 
gating on cells with high levels of active caspase-3. (c) Percent DNA damagehigh, 
apoptosislow cells, measured by gating on 8-oxoguanosinehigh, active caspase-3low cells. In 
a-c, 7–10 gerbils were used in uninfected groups, and 20 gerbils were used in infected 
groups. For a–c, **P < 0.01, ***P < 0.001 versus control uninfected; §P < 0.05, §§P < 0.01, 
§§§P < 0.001 versus PZ5056G non-treated. Solid symbols represent gerbils with dysplasia 
or carcinoma.
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